Results 81 to 90 of about 322 (146)

Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. [PDF]

open access: yesDrugs R D, 2010
Nunes T   +7 more
europepmc   +1 more source

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor. [PDF]

open access: yesBr J Clin Pharmacol, 2014
Loureiro AI   +6 more
europepmc   +1 more source

Occupational cancer in Spain. [PDF]

open access: yesEnviron Health Perspect, 1999
González CA, Agudo A.
europepmc   +1 more source

Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat. [PDF]

open access: yesBr J Pharmacol, 2015
Bonifácio MJ   +5 more
europepmc   +1 more source

Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics. [PDF]

open access: yesBr J Clin Pharmacol, 2017
Rocha JF   +10 more
europepmc   +1 more source

Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects. [PDF]

open access: yesBr J Clin Pharmacol, 2013
Rocha JF   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy